FAST-BOLUS

FAST-BOLUS

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description
This study measures plasma biomarkers in children enrolled in PRoMPT BOLUS with existing stored samples which were collected at randomization in order to assess the for differential effects of fluid assignment on MAKE30 across risk strata using two distinct biomarker-based mortality prediction models (Aim 1) and separately across two different biomarker-defined inflammatory sub-phenotypes (Aim 2). The study will also leverage this biobank to investigate potential mechanisms between fluid choice and MAKE30 by measuring markers of endothelial cell and endothelial glycocalyx damage (Aim 3).

Eligibility and criteria
IRB Number:
21-019471
Eligible age range:
6 months - 17.9 years
Clinical trial phase:
N/A
Official title:
Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis

What to expect

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.